Real-time Deflectable Guidewire in Neuro-interventions Study
- Conditions
- Unruptured Cerebral Aneurysm
- Interventions
- Device: Standard of care guidewire (different models may be used)Device: Deflectable guidewire
- Registration Number
- NCT05564325
- Lead Sponsor
- Artiria Medical
- Brief Summary
The aim of the study is to assess the safe and successful use of the SmartGUIDE guidewire in neuro interventions and to compare to standard of care guidewires on the market.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 75
- >18 years of age
- Informed consent signed by patient
- Confirmed cerebral unruptured aneurysm treatable via transcatheter approach
- Pregnancy or lactation
- Known disorder of vascular fragility with propensity to vascular injury (e.g., Ehlers-Danlos syndrome)
- Known prior vascular stenosis or dissection or injury to vessels intended to be catheterized during study procedures
- Acute phase myocardial infarction or uncontrolled cardiac arrhythmia
- Uncontrolled serum electrolyte imbalance
- Bleeding disorder which limits the use of antiplatelet and/or anticoagulant therapy
- Known contraindication to intravascular contrast material that cannot be adequately controlled with pre-medication
- Known hypersensitivity to Nickel
- Subjects currently enrolled in another investigational device or drug study that clinically interferes with the current study endpoints
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Standard of care guidewire Standard of care guidewire (different models may be used) - Deflectable guidewire Deflectable guidewire -
- Primary Outcome Measures
Name Time Method Performance During index procedure Intra-procedural technical success defined as successful navigation of device to the vascular target vessel without need for shaping, removal or exchange.
- Secondary Outcome Measures
Name Time Method Procedural times During index procedure Procedural times (duration of tip reshaping, duration of access to target, duration of fluoroscopic exposition).
Safety - intra- and postprocedural During index procedure and up to 48 hours post procedure Adverse events, measured by the occurrence of adverse events
Device Deficiencies During index procedure Intraprocedural device deficiencies, measured by the occurrence of device deficiencies/malfunctions
Usability During index procedure Usability data (pushability, trackability, navigatability, shape retention, support, and proximal access complexity) collected through questionnaire completed by the physician. Measured through a Likert scale from 1-5.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
Centre Hospitalier Universitaire Vaudois (CHUV)
🇨🇭Lausanne, Switzerland
Geneva University Hospital - HUG
🇨🇭Geneva, Switzerland